Spontaneous antral follicle formation and metaphase II oocyte from a non-stimulated prepubertal ovarian tissue xenotransplant
- Laura Lotz†1,
- Jana Liebenthron†2,
- Stephanie M Nichols-Burns1,
- Markus Montag3,
- Inge Hoffmann1,
- Matthias W Beckmann1,
- Hans van der Ven2,
- Dagmar Töpfer4 and
- Ralf Dittrich1Email author
© Lotz et al.; licensee BioMed Central Ltd. 2014
Received: 11 February 2014
Accepted: 26 April 2014
Published: 15 May 2014
Current strategies in cancer treatment have markedly increased the rates of remission and survival for cancer patients, but are often associated with subsequent sterility. While there are various options available to an adult female depending on the patient’s particular situation, the only realistic option for preserving fertility in prepubertal females is to cryopreserve ovarian tissue. This is the first report of a morphologically mature oocyte collected from non-stimulated prepubertal ovarian tissue xenotransplants.
Ovarian tissue from a 6 year old patient suffering from nephroblastoma was removed and cryopreserved for fertility preservation. The frozen-thawed ovarian tissue fragments were xenotransplanted to bilaterally oophorectomized severe combined immunodeficiency (SCID) mice to assess follicle development.
Antral follicle formation occurred post-xenotransplantation in a single ovarian fragment without exogenous hormone stimulation. A morphologically maturing oocyte was harvested from these follicles.
Prepubertal human ovarian follicles and oocytes can be matured after xenotransplantation even without exogenous hormone stimulation. These results indicate that tissue collected from prepubertal patients can support fertility in cancer survivors.
Advances in the treatment of oncological diseases have led to greater survival rates for patients. However, treatment often includes gonadotoxic therapies, which can deplete germ cells and, in females, may result in premature ovarian failure in cancer survivors. While there are various routes available to an adult female depending on the patient’s particular situation, the only realistic option for preserving fertility in prepubertal females is to cryopreserve ovarian tissue [1–4]. This technique is a promising tool because the ovarian cortex contains a large pool of follicles [5, 6] and provides a high developmental potential, especially in prepubertal patients [7, 8].
The few transplantation studies of frozen-thawed prepubertal ovarian tissue that have been reported indicate that these grafts can support induction of puberty in young cancer survivors [9, 10] and may presumably support reproduction at the appropriate time. These results, coupled with reports of more than 24 live births resulting from ovarian tissue cryopreservation and later transplantation to women , demonstrate the potential of the technique to move from the experimental realm to routine clinical practice.
We report here the occurrence of spontaneous antral follicle formation and oocyte maturation in an ovarian tissue transplant from a prepubescent girl (6 years old at the time of biopsy). To our knowledge, this is the first report of a morphologically mature oocyte collected from non-stimulated prepubertal ovarian tissue xenotransplants. These results further support the position that tissue collected from these young patients can support fertility in cancer survivors.
In 2009 ovarian tissue from a 6 year old patient suffering from nephroblastoma was removed and cryopreserved following informed consent and approval of the local university ethical committee (University Women’s Hospital, Bonn, Germany). About half of the ovarian cortex was removed via laparotomy in the therapeutically surgery for the nephroblastom from both ovaries. This patient and her parents were interested in cryopreserving ovarian tissue for fertility preservation and to contribute to research efforts in this area. Less than 5% of the frozen tissue was used for this experiment. A histological examination of the ovarian cortex was performed prior to cryopreservation in order to secure a sufficient amount of primordial follicles and exclude involvement of the tissue by malignancy.
Ovarian tissue freezing and thawing
Details of the cryopreservation and thawing protocols for ovarian cortex tissue have been previously described. In brief, ovarian tissue biopsies were cut into pieces measuring 1 × 2 × 1 mm and equilibrated in a freezing solution containing 1.5 mol/L dimethylsulfoxide (DMSO) in Leibovitz medium. The pieces of ovarian tissue were then frozen in standard cryopreservation containers (1.8 mL Nunc cryovials) using a slow-cooling protocol with a closed freezing system (Icecube 14S; Sylab) with autoseeding. Cryopreserved ovarian tissue fragments were transported in a liquid nitrogen dewar to the Erlangen University Hospital (Erlangen, Germany) for thawing and transplantation experiments. Rapid thawing took place in a warm water bath (37°C until thawing). Tissue fragments were exposed in a step-wise manner to decreasing sucrose concentrations to release it from the protective cryopreservation medium .
Female SCID mice (6 weeks old, Harlan-Winkelmann, Borchen, Germany) were housed in a high efficiency particulate air-filtered positive pressure room. Cages (Techniplast, Milano, Italy) were filter-topped and animals had access to food (Altromin 1314, Altromin, Lage, Germany) and water ad libitum under 12 h light: 12 h dark conditions. Groups of 5 mice were housed in 1 cage. Mice underwent a 1 week acclimation period upon arrival at the facility. All procedures and tests were performed under a laminar flow hood in a positive pressure room. Approval for the study was obtained from the local ethical committee on animal experimentation (Erlangen University Hospital, Erlangen, Germany). Animals were maintained in accordance with Animal Care and Use Committee regulations.
Surgery was performed under anesthesia with isoflurane (Isoflo® ad us. vet., Abott AG, Baar, Germany). Transplantation was performed irrespective of the estrous cycle stage. Mice ovaries were removed and 1 frozen/thawed human ovarian tissue fragment was placed in an intramuscular pocket of the neck. Grafting experiments were carried out in multiple rounds to ensure optimal technical handling and minimize the number of sacrificed animals.
Treatment of the xenografted ovarian tissue
In this particular study, SCID mice and their grafted tissue were not exposed to any exogenous hormones. The finding was part of a larger study comparing prepubertal ovarian tissue growth in vivo versus in vitro. Exogenous hormone administration was not part of the experimental protocol in either case.
Graft observations and oocyte retrieval
Study animals were observed daily for behavior, health and follicle growth was monitored with palpation of the neck. On the occasion that a lump was witnessed at the graft site, the animal was put under general anesthesia (isoflurane, 5%) and any apparent antral follicles were aspirated using a customized sterile needle (20G Supra, Karl Lettenbauer GmbH, Erlangen, Germany), specially beveled and sharpened for ease of aspiration and to minimize trauma to surrounding tissue at the site of action. The aspirate was inspected for the presence of oocytes. Products were placed into warmed and equilibrated culture medium without exogenous gonadotropins (Universal IVF Medium; Origio, Malov, Denmark), examined for meiotic stage and then placed into a 37°C incubator (5% CO2 in air) for in vitro culture. The animal was returned to its cage for continued observation following the procedure.
Ovarian tissue cryopreservation and transplantation is proving to be a promising avenue for fertility preservation. Initial studies on the potential of this technique focused mainly on adult females for whom maintenance of fertility may be more of an immediate issue after cancer treatment. Information gleaned from these studies may be extrapolated to the adolescent female, for whom many of the current options of preserving fertility are not possible or appropriate. Optimization of ovarian tissue collection, preservation and later thawing and transplantation are of the utmost importance in either situation. In the adolescent female in particular, following full recovery from cancer, the goal of ovarian transplantation is to support the induction of puberty, establish hormonal cyclicity and the conditions for the possibility of an eventual pregnancy.
The prepubertal ovary has been demonstrated to contain a population of follicles in all stages of growth in exception of preovulatory stages [5, 6]. However, there appear to be intrinsic differences between the adolescent and sexually mature ovary that prevent the adolescent ovary from developing fully mature follicles and oocytes in situ. It is not clear what these differences may be or what factors may be involved. Anderson et al. report that intrafollicular dynamics, local environment and maturational processes that change within the ovary as a girl ages are all likely involved to varying degrees . Luyckx et al.  were the first to demonstrate follicles contained in prepubertal ovarian tissue can be expected to function, once transplanted, in a manner comparable to ovarian tissue from an adult or sexually mature female. In an effort to improve transplant outcome, the addition of exogenous hormone stimulation has been implemented [8, 14]. Luyckx et al.  demonstrated success in survival and development of frozen-thawed preantral follicles from prepubescent patients after xenotransplantation in SCID mice and exogenous hormone stimulation. The result of finding a Met II oocyte in this study affirms the results published by Luyckx et al. . The few studies that have reported results from the autotransplantation of frozen-thawed prepubertal ovarian tissue demonstrate the possibility of this tissue to induce puberty and provide some hope for other prepubertal patients [9, 10]. Establishment of follicular development and hormonal activity in frozen-thawed transplanted prepubertal ovarian tissue has also been demonstrated in animal models (mouse: [15–17]; nonhuman primate: ; sheep: ). These results demonstrate the potential of prepubertal ovarian tissue and further success can be expected as our understanding of underlying processes and technique development evolve.
In the current study spontaneous antral follicle formation and oocyte maturation in a prepubertal ovarian tissue xenotransplant occurred which is in accordance to the finding that within grafts of adult women spontaneous follicle development can take place . To our knowledge, this is the first report of antral follicular formation and oocyte maturation without exogenous hormone administration in a frozen-thawed ovarian tissue transplant obtained from a prepubertal patient. Follicle growth was estimated to be to approximately 7 mm in width and the obtained oocyte measured 150 μm. The zona pellucida (ZP) was thin (14,6 μm), but did not significantly vary from ZP witnessed in mature oocytes obtained from stimulated in vitro fertilization (IVF) cycles (). This result complements reports on the potential of frozen-thawed prepubertal tissue to successfully establish follicular activity [9, 10] and indicates for the first time that prepubertal tissue can produce mature oocytes after xenotransplantation, even without gonadotropin stimulation. This may be advantageous for graft survival since it has been shown that prolonged gonadotropin stimulation may cause a loss of primordial follicles in xenografts [22–24] or in vitro .
There will be cases when transplantation will not be indicated due to presence of malignant cells within the transplant [26–28]. Xenotransplantation could be an option to obtain oocytes which can be used for achieving pregnancies of these patients. In vitro maturation (IVM) of oocytes provides an alternative and complementary technique. This can be accomplished in several ways to include: supplementary oocyte aspiration from ovarian tissue prior to ovarian tissue cryopreservation [29, 30], these oocytes may be immediately cultured to maturity or cryopreserved; in vitro culture of the ovarian tissue post-thaw to produce antral follicle development and harvest mature oocytes from the excised tissue either for immediate use in IVF or for cryopreservation. Another promising option is an artificial ovary with isolated follicles as very recently described . These avoid the potential risk of reintroducing malignant cells and increase opportunities for the patient’s future reproductive health and options.
Our finding suggests that it may be possible to accomplish oocyte maturation during in vitro culture of prepubertal ovarian tissue, whether within isolated encapsulated follicles or within the ovarian tissue slice itself [7, 8]. The SCID mouse essentially acts as a kind of optimal incubator and ovarian growth within this system may be mimicked in vitro once ideal conditions have been established. Future studies will continue to focus on optimizing conditions for in vitro growth of ovarian tissue in parallel with the goals of resumption of hormonal cyclicity, follicle growth and activity, and oocyte maturation (cytoplasmic and morphological) in transplanted tissue.
Research for this study was supported by grants from the Wilhelm Sander Foundation (reference no. 2008.086.1 and no. 2012.127/1), Munich, Germany, and the German Research Association (Deutsche Forschungsgemeinschaft; DI 1525/4-1).
- Jadoul P, Dolmans MM, Donnez J: Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?. Hum Reprod Update. 2010, 16: 617-630. 10.1093/humupd/dmq010.View ArticlePubMedGoogle Scholar
- Song Y, Sharp R, Lu F, Hassan M: The future potential of cryopreservation for assisted reproduction. Cryobiology. 2010, 60: S60-S65. 10.1016/j.cryobiol.2009.09.009.PubMed CentralView ArticlePubMedGoogle Scholar
- Anderson RA, Wallace WH: Fertility preservation in girls and young women. Clin Endocrinol. 2011, 75: 409-419. 10.1111/j.1365-2265.2011.04100.x.View ArticleGoogle Scholar
- Dittrich R, Lotz L, Keck G, Hoffmann I, Mueller A, Beckmann MW, van der Ven H, Montag M: Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012, 97: 387-390. 10.1016/j.fertnstert.2011.11.047.View ArticlePubMedGoogle Scholar
- Lintern-Moore S, Peters H, Moore GP, Faber M: Follicular development in the infant human ovary. J Reprod Fertil. 1974, 39: 53-64. 10.1530/jrf.0.0390053.View ArticlePubMedGoogle Scholar
- Peters H, Byskov AG, Grinsted J: Follicular growth in fetal and prepubertal ovaries of humans and other primates. Clin Endocrinol Metab. 1978, 7: 469-485. 10.1016/S0300-595X(78)80005-X.View ArticlePubMedGoogle Scholar
- Fabbri R, Vicenti R, Macciocca M, Pasquinelli G, Lima M, Parazza I, Magnani V, Venturoli S: Cryopreservation of ovarian tissue in pediatric patients. Obstet Gynecol Int. 2012, 2012: 910698-PubMed CentralView ArticlePubMedGoogle Scholar
- Luyckx V, Scalercio S, Jadoul P, Amorim CA, Soares M, Donnez J, Dolmans MM: Evaluation of cryopreserved ovarian tissue from prepubertal patients after long-term xenografting and exogenous stimulation. Fertil Steril. 2013, 100: 1350-1357. 10.1016/j.fertnstert.2013.07.202.View ArticlePubMedGoogle Scholar
- Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P: Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet. 2012, 379: 588-10.1016/S0140-6736(11)61781-9.View ArticlePubMedGoogle Scholar
- Ernst E, Kjaersgaard M, Birkebaek NH, Clausen N, Andersen CY: Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer (Oxford, England: 1990). 2013, 49: 911-914. 10.1016/j.ejca.2012.09.028.View ArticleGoogle Scholar
- Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, Ernst E, Luyckx V, Andersen CY: Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013, 99: 1503-1513. 10.1016/j.fertnstert.2013.03.030.View ArticlePubMedGoogle Scholar
- Isachenko V, Isachenko E, Reinsberg J, Montag M, Braun F, van der Ven H: Cryopreservation of human ovarian tissue: effect of spontaneous and initiated ice formation. Reprod BioMed Online. 2008, 16: 336-345. 10.1016/S1472-6483(10)60593-7.View ArticlePubMedGoogle Scholar
- Anderson RA, McLaughlin M, Wallace WH, Albertini DF, Telfer EE: The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence. Hum Reprod (Oxford, England). 2014, 29: 97-106. 10.1093/humrep/det388.View ArticleGoogle Scholar
- Yang HY, Cox SL, Jenkin G, Findlay J, Trounson A, Shaw J: Graft site and gonadotrophin stimulation influences the number and quality of oocytes from murine ovarian tissue grafts. Reproduction (Cambridge, England). 2006, 131: 851-859. 10.1530/rep.1.00916.View ArticleGoogle Scholar
- Carroll J, Gosden RG: Transplantation of frozen-thawed mouse primordial follicles. Hum Reprod (Oxford, England). 1993, 8: 1163-1167.Google Scholar
- Sauvat F, Capito C, Sarnacki S, Poirot C, Bachelot A, Meduri G, Dandolo L, Binart N: Immature cryopreserved ovary restores puberty and fertility in mice without alteration of epigenetic marks. PLoS One. 2008, 3: e1972-10.1371/journal.pone.0001972.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang HY, Li YH, Sun L, Gao X, You L, Wang Y, Ma JL, Chen ZJ: Allotransplantation of cryopreserved prepubertal mouse ovaries restored puberty and fertility without affecting methylation profile of Snrpn-DMR. Fertil Steril. 2013, 99: 241-247. 10.1016/j.fertnstert.2012.08.030.View ArticlePubMedGoogle Scholar
- von Schonfeldt V, Chandolia R, Kiesel L, Nieschlag E, Schlatt S, Sonntag B: Advanced follicle development in xenografted prepubertal ovarian tissue: the common marmoset as a nonhuman primate model for ovarian tissue transplantation. Fertil Steril. 2011, 95: 1428-1434. 10.1016/j.fertnstert.2010.11.003.View ArticlePubMedGoogle Scholar
- Sauvat F, Bouilly J, Capito C, Lefevre A, Blachere T, Borenstein N, Sarnacki S, Dandolo L, Binart N: Ovarian function is restored after grafting of cryopreserved immature ovary in ewes. FASEB J: Publ Fed Am Soc Exp Biol. 2013, 27: 1511-1518.View ArticleGoogle Scholar
- Lotz L, Schneider H, Hackl J, Wachter D, Hoffmann I, Jurgons R, Beckmann MW, Dittrich R: Does stimulation with human gonadotropins and gonadotropin-releasing hormone agonist enhance and accelerate the developmental capacity of oocytes in human ovarian tissue xenografted into severe combined immunodeficient mice?. Fertil Steril. 2014, 101: 1477-84.e3. 10.1016/j.fertnstert.2014.01.038.View ArticlePubMedGoogle Scholar
- Marco-Jimenez F, Naturil-Alfonso C, Jimenez-Trigos E, Lavara R, Vicente JS: Influence of zona pellucida thickness on fertilization, embryo implantation and birth. Anim Reprod Sci. 2012, 132: 96-100. 10.1016/j.anireprosci.2012.04.008.View ArticlePubMedGoogle Scholar
- Maltaris T, Beckmann MW, Mueller A, Hoffmann I, Kohl J, Dittrich R: Significant loss of primordial follicles after prolonged gonadotropin stimulation in xenografts of cryopreserved human ovarian tissue in severe combined immunodeficient mice. Fertil Steril. 2007, 87: 195-197. 10.1016/j.fertnstert.2006.05.058.View ArticlePubMedGoogle Scholar
- Imthurn B, Cox SL, Jenkin G, Trounson AO, Shaw JM: Gonadotrophin administration can benefit ovarian tissue grafted to the body wall: implications for human ovarian grafting. Mol Cell Endocrinol. 2000, 163: 141-146. 10.1016/S0303-7207(00)00218-5.View ArticlePubMedGoogle Scholar
- Dissen GA, Lara HE, Fahrenbach WH, Costa ME, Ojeda SR: Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology. 1994, 134: 1146-1154.PubMedGoogle Scholar
- Wang Y, Chang Q, Sun J, Dang L, Ma W, Hei C, Shen X, Zhao C, Cai Y, Pei X, Zhang X, Wang Y, Jiang X: Effects of HMG on revascularization and follicular survival in heterotopic autotransplants of mouse ovarian tissue. Reprod Biomed Online. 2012, 24: 646-653. 10.1016/j.rbmo.2012.02.025.View ArticlePubMedGoogle Scholar
- Dolmans MM, Luyckx V, Donnez J, Andersen CY, Greve T: Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013, 99: 1514-1522. 10.1016/j.fertnstert.2013.03.027.View ArticlePubMedGoogle Scholar
- Kim SS, Radford J, Harris M, Varley J, Rutherford AJ, Lieberman B, Shalet S, Gosden R: Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod (Oxford, England). 2001, 16: 2056-2060. 10.1093/humrep/16.10.2056.View ArticleGoogle Scholar
- Shaw JM, Bowles J, Koopman P, Wood EC, Trounson AO: Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod (Oxford, England). 1996, 11: 1668-1673. 10.1093/oxfordjournals.humrep.a019467.View ArticleGoogle Scholar
- Revel A, Revel-Vilk S, Aizenman E, Porat-Katz A, Safran A, Ben-Meir A, Weintraub M, Shapira M, Achache H, Laufer N: At what age can human oocytes be obtained?. Fertil Steril. 2009, 92: 458-463. 10.1016/j.fertnstert.2008.07.013.View ArticlePubMedGoogle Scholar
- Dittrich R, Lotz L, Mueller A, Hoffmann I, Wachter DL, Amann KU, Beckmann MW, Hildebrandt T: Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod Biol Endocrinol: RB&E. 2013, 11: 19-10.1186/1477-7827-11-19.View ArticleGoogle Scholar
- Luyckx V, Dolmans MM, Vanacker J, Scalercio SR, Donnez J, Amorim CA: First step in developing a 3D biodegradable fibrin scaffold for an artificial ovary. J Ovarian Res. 2013, 6: 83-10.1186/1757-2215-6-83.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.